Skip to content
Project Description
Our pharmaceutical advertising work for Methylphenidate.
Methylphenidate is a drug that approached household-name status under a different brand—Ritalin. With its quick-release, chewable dose, Lupin’s Methylphenidate formulation offered distinct advantages for specific patients and therapeutic situations—something we capitalized on in our patient-centered branding.
Along with the full gamut of physical collateral for healthcare providers and a website for both providers and patients, we created a wealth of patient support materials to help parents, children, and adult ADHD sufferers understand the place of Methylphenidate in managing ADHD.
